Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 43 articles: HTML format

Single Articles

April 2026
1. WANG R, Huang CC, Becerra MC, Calderon RI, et al
   Transmissibility and Disease Progression of Asymptomatic Mycobacterium tuberculosis Infection, Lima, Peru.
   Emerg Infect Dis. 2026;32.
   PubMed     Abstract available
   
   
   March 2026
2. PUVIANI FC, Zaffagnini A, Mazzi C, Cirillo DM, et al
   Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe.
   Emerg Infect Dis. 2026;32:469-471.
   PubMed     Abstract available
   
   
   
3. POIGNON C, Vandenbos F, Risso K, Viard D, et al
   Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France.
   Emerg Infect Dis. 2026;32:449-451.
   PubMed     Abstract available
   
   
   
4. AHSON M, Shah D, Bhide S, Deshmukh R, et al
   Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024.
   Emerg Infect Dis. 2026;32:419-423.
   PubMed     Abstract available
   
   
   
5. TEMPLIN L, Varajidas Y, Respeito D, Zindoga P, et al
   Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique.
   Emerg Infect Dis. 2026;32:409-413.
   PubMed     Abstract available
   
   
   
6. FENG PI, Phares CR, Pratt R, Self JL, et al
   Tuberculosis before and during COVID-19 Pandemic, United States, 2010-2023.
   Emerg Infect Dis. 2026;32:388-396.
   PubMed     Abstract available
   
   
   
7. MACHADO M, Jordan AE, Schwalb A, Houben RMGJ, et al
   Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024-2050.
   Emerg Infect Dis. 2026;32:332-340.
   PubMed     Abstract available
   
   
   December 2025
8. KURBATOVA EV, Whitworth WC, Bryant KE, Dixon MG, et al
   Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.
   Emerg Infect Dis. 2025;31:2233-2242.
   PubMed     Abstract available
   
   
   November 2025
9. SEUNG KJ, Asfaw M, Kunda M, Maama-Maime LB, et al
   Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.
   Emerg Infect Dis. 2025;31:2185-2187.
   PubMed     Abstract available
   
   
   October 2025
10. GUO C, Pan Y, Yu J, Yao L, et al
    Disseminated Blastomycosis Mimicking Tuberculosis, China.
    Emerg Infect Dis. 2025;31:2046-2048.
    PubMed     Abstract available
    
    
    July 2025
11. ROY A, Gomez-Barroso D, Cruz-Ferro E, Fernandez A, et al
    Spatiotemporal Distribution and Clinical Characteristics of Zoonotic Tuberculosis, Spain, 2018-2022.
    Emerg Infect Dis. 2025;31:1344-1352.
    PubMed     Abstract available
    
    
    
12. ASAY GRB, Young KH, Hill TD, Njie GJ, et al
    Systematic Review of Contact Investigation Costs for Tuberculosis, United States.
    Emerg Infect Dis. 2025;31:1284-1293.
    PubMed     Abstract available
    
    
    March 2025
13. PAUL R, Lorenzo F, Lopez B, Alegre MG, et al
    Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006-2022.
    Emerg Infect Dis. 2025;31:601-606.
    PubMed     Abstract available
    
    
    
14. KLINKENBERG E, de Haas P, Manyonge C, Namutebi J, et al
    Lessons Learned from Early Implementation and Scale-up of Stool-Based Xpert Testing to Diagnose Tuberculosis in Children.
    Emerg Infect Dis. 2025;31:1-9.
    PubMed     Abstract available
    
    
    
15. GERUSSI V, Petersen T, Bonnet I, Aubry A, et al
    Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.
    Emerg Infect Dis. 2025;31:633-636.
    PubMed     Abstract available
    
    
    
16. FRANCISCO NM, Gaviraghi A, Alladio F, Huits R, et al
    Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola.
    Emerg Infect Dis. 2025;31:627-629.
    PubMed     Abstract available
    
    
    
17. KONSTANTYNOVSKA O, Synenko T, Honcharenko A, Volobuieva O, et al
    Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
    Emerg Infect Dis. 2025;31:615-617.
    PubMed     Abstract available
    
    
    
18. JUNG E, Alarcon VA, Solis Tupes WS, Avalos-Cruz T, et al
    National Active Case-Finding Program for Tuberculosis in Prisons, Peru, 2024.
    Emerg Infect Dis. 2025;31:564-568.
    PubMed     Abstract available
    
    
    
19. SHRESTHA S, Cilloni L, Asay GRB, Kammerer JS, et al
    Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United States.
    Emerg Infect Dis. 2025;31:497-506.
    PubMed     Abstract available
    
    
    
20. ZIMENKOV D, Ushtanit A, Gordeeva E, Guselnikova E, et al
    High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia.
    Emerg Infect Dis. 2025;31:525-536.
    PubMed     Abstract available
    
    
    
21. KURBATOVA EV, Whitworth WC, Peddareddy LP, Phillips PPJ, et al
    Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
    Emerg Infect Dis. 2025;31:467-476.
    PubMed     Abstract available
    
    
    November 2024
22. GORVETZIAN S, Pacheco AG, Anderson E, Ray SM, et al
    Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019.
    Emerg Infect Dis. 2024;30:2261-2270.
    PubMed     Abstract available
    
    
    August 2024
23. MCQUAID CF, Ryckman TS, Menzies NA, White RG, et al
    Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
    Emerg Infect Dis. 2024;30:1571-1579.
    PubMed     Abstract available
    
    
    July 2024
24. LUKOYE D, Kalamya JN, Awor AC, Gustavson G, et al
    Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020.
    Emerg Infect Dis. 2024;30:1402-1405.
    PubMed     Abstract available
    
    
    June 2024
25. TAN Q, Huang CC, Becerra MC, Calderon R, et al
    Chest Radiograph Screening for Detecting Subclinical Tuberculosis in Asymptomatic Household Contacts, Peru.
    Emerg Infect Dis. 2024;30:1115-1124.
    PubMed     Abstract available
    
    
    April 2024
26. FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al
    Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
    Emerg Infect Dis. 2024;30:1-5.
    PubMed     Abstract available
    
    
    
27. DAHL VN, Butova T, Rosenthal A, Grinev A, et al
    Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.
    Emerg Infect Dis. 2024;30:831-833.
    PubMed     Abstract available
    
    
    
28. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    PubMed     Abstract available
    
    
    March 2024
29. SPIES R, Hong HN, Trieu PP, Lan LK, et al
    Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
    Emerg Infect Dis. 2024;30:499-509.
    PubMed     Abstract available
    
    
    
30. GUNTHER G, Mhuulu L, Diergaardt A, Dreyer V, et al
    Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
    Emerg Infect Dis. 2024;30:568-571.
    PubMed     Abstract available
    
    
    January 2024
31. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    PubMed     Abstract available
    
    
    
32. HUMAYUN M, Mukasa L, Ye W, Bates JH, et al
    Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA, 2010-2021.
    Emerg Infect Dis. 2024;30:116-124.
    PubMed     Abstract available
    
    
    
33. NSENGIYUMVA NP, Khan A, Gler MMTS, Tonquin ML, et al
    Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018-2021.
    Emerg Infect Dis. 2024;30:79-88.
    PubMed     Abstract available
    
    
    December 2023
34. LAFLEUR M, Rasoanaivo HA, Andrianarivo TH, Andrianomanana FR, et al
    Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022.
    Emerg Infect Dis. 2023;29:2587-2589.
    PubMed     Abstract available
    
    
    November 2023
35. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    PubMed     Abstract available
    
    
    October 2023
36. WINSTON CA, Marks SM, Carr W
    Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States.
    Emerg Infect Dis. 2023;29:2102-2104.
    PubMed     Abstract available
    
    
    August 2023
37. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available
    
    
    
38. LOUIE JK, Agraz-Lara R, Romo L, Deiterich C, et al
    Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA.
    Emerg Infect Dis. 2023;29:1651-1654.
    PubMed     Abstract available
    
    
    July 2023
39. WOODRUFF R, Miramontes R
    Tuberculosis Infection among Non-US-Born Persons and Persons >/=60 Years of Age, United States, 2019-2020.
    Emerg Infect Dis. 2023;29:1470-1472.
    PubMed     Abstract available
    
    
    May 2023
40. NOROC E, Chesov D, Merker M, Groschel MI, et al
    Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
    Emerg Infect Dis. 2023;29:1046-1050.
    PubMed     Abstract available
    
    
    
41. NGUYEN HV, Brals D, Tiemersma E, Gasior R, et al
    Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017-2018.
    Emerg Infect Dis. 2023;29:967-976.
    PubMed     Abstract available
    
    
    
42. BAKER CR, Barilar I, de Araujo LS, Rimoin AW, et al
    Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.
    Emerg Infect Dis. 2023;29:977-987.
    PubMed     Abstract available
    
    
    
43. MILLARD J, Rimmer S, Nimmo C, O'Donnell M, et al
    Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB.
    Emerg Infect Dis. 2023;29:1081-1084.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum